Dr. Thinzar Lin, MD

Dr. Lin practices at United Asian Medical in New York, New York.

Dr. Lin's NPI, 1932509205, was assigned on August 24, 2014. Dr. Lin holds New York license 296775.

Dr. Lin's primary practice is United Asian Medical, at 185 Canal St, New York, NY 10013-4537. The practice phone is (212) 226-1177.

Dr. Lin's primary practice is United Asian Medical in New York, New York. Dr. Lin is also affiliated with Maimonides Medical Center. The medical group on file is Maimonides Medical Center. Dmand AI also links Dr. Lin to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 4 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Lin is licensed in New York.

CMS data shows 350 Medicare services from Dr. Lin across 7 procedure codes in 2024, for 190 Medicare patients. Medicare paid $32,365 for them.

CMS counts 190 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have diabetes, and 75% have high blood pressure. 47% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 63, with 68% women.

In 2024, Dr. Lin wrote 2,400 Medicare Part D claims for 286 patients. 44% of them were for generic drugs. CMS names the drug for 2,046 of them, across 45 drugs with 11 or more claims each, at $830,869 in total drug cost. In 2023, CMS named 1,586 claims across 39 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 4 papers to Dr. Lin, published from 2016 to 2018. 2017 was the busiest year, with 2. Dr. Lin has published most often in Case Rep Gastroenterol. Dr. Lin's most frequent co-authors are Sithu Lin, MD, Madhavi Reddy, MD and Madhavi Reddy, MD.

CMS Open Payments shows 1 general payment to Dr. Lin from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $35.